The FDA has expanded the approval of Fanapt® (iloperidone) to include the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The approval was based on data from a phase 3 study that included approximately 400 adults with a history of bipolar I disorder who had a current episode of mania.